Deal of the Day — limited-time pharmacy picks!
Vivitra 440mg Injection

Vivitra 440mg Injection

Prescription requiredRx Required

Salt Composition: Trustuzumab

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 Injection

About The Product

  • ​Breast Cancer​
  • Gastric cancer
  • Vivitra 440mg Injection is an anticancer medicine that helps to treat breast, gastric, and gastroesophageal cancer.
  • It is used when cancer cells spread to other parts of the body. Trastuzumab, the active ingredient in Vivitra 440mg Injection, is used for the treatment of HER2 breast cancer.
  • Additionally, metastatic gastric cancer with elevated HER2 protein levels is treated with this drug.
  • For patients under the age of 18, as well as those who require oxygen therapy or have serious respiratory issues, Trustuzumab 440mg Injection is not advised.
  • If you have ever received any kind of cancer therapy, have cardiac issues, or experience dyspnea, you must inform your doctor. Before beginning therapy with this medication, make sure you tell your doctor about all the medications you are taking, including herbal and supplement medications.

Uses

Vivitra 440mg Injection is indicated for use in the following conditions:

  • HER2-positive breast cancer
  • HER2-positive metastatic gastric (stomach) cancer

Side Effects

​Vivitra 440mg Injection causes several side effects, which are unwanted symptoms that include:

  • Chills and Cough
  • Anemia
  • Decrease in blood cell counts
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Mucosal inflammation
  • Infection in the upper respiratory
  • Weight loss

If the patients are suffering from the above-mentioned symptoms, do not avoid these symptoms because this injection has severe side effects. Try to contact the doctor immediately for urgent help.

Dosage and Administration

  • Vivitra is taken in injection form as per the doctor's prescription.
  • The patients should take this injection from a qualified medical professional.
  • Do not self-administer.

Mechanism of action

  • ​Vivitra 440mg binds the HER2 protein on the surface of cancer cells.
  • The blocking of the HER2 receptor stops signaling, which will stop the growth and division of cancer cells in the patient's body.
  • The benefits of the injection are seen in a few weeks or months, depending on the health of the patients after starting treatment.
  • However, to see the full benefit, it can take several months or years. As to healthcare professionals.
  • Vivitra is a powerful and very effective injection for the treatment of breast cancer.
  • However, patients need to discuss benefits and side effects at the beginning of treatment.

Safety Advice

Alcohol
It is advisable to consult your doctor while taking medicine, as the interaction of this injection with alcohol is not known.
Pregnancy
Do not take Vivitra 440mg Injection without consulting the doctor; in case of pregnancy, it may cause harm to the fetus.
Breast Feeding
Without a doctor's consultation, do not take this medicine if you're breastfeeding.
Driving
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.
Kidney
Do not take Vivitra 440mg Injection without a doctor's consultation in case of kidney problems.
Liver
Share your medical history with the doctor in case of liver disease before taking this medicine.

Missed Doses

  • It is advisable not to miss any dose.
  • In case you miss a dose of Vivitra 440mg Injection consult your doctor soon.
  • Missing the dose will impact the overall health of the patients.
  • So, it is always advisable to follow the prescription of the doctor strictly.

FAQs

The Vivitra injection is used to treat breast, gastric, and gastroesophageal cancer.


References

  • Wierzbicki, R., Slamon, D. J., Leyland‑Jones, B., Shak, S., Fuchs, H., Paton, V. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.  New England Journal of Medicine, 344(11), 783–792. https://pubmed.ncbi.nlm.nih.gov/11248153/
  • Gelber, R. D., Piccart‑Gebhart, M. J., Procter, M., Leyland‑Jones, B., Goldhirsch, A., Untch, M. (2005). Trastuzumab after adjuvant chemotherapy in HER2‑positive breast cancer. New England Journal of Medicine, 353(16), 1659–1672. https://pubmed.ncbi.nlm.nih.gov/16236737/
  • Tabernero, J., Bang, Y.‑J., Van Cutsem, E., Feyereislova, A., Chung, H.‑C., Shen, L. (2010). Trastuzumab in combination with chemotherapy versus chemotherapy alone for HER2‑positive advanced gastric or gastroesophageal junction cancer: a phase III, open‑label, randomised controlled trial (ToGA). Lancet, 376(9742), 687–697. https://pubmed.ncbi.nlm.nih.gov/20728210/
  • Zydus Cadila. (2025). Vivitra™ (trastuzumab) prescribing information. Retrieved from the company's information site Macarius Health. (2025). Vivitra 440 mg injection (biosimilar trastuzumab): Product profile. Retrieved from the oncology product database

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026